Preclinical development of a TALEN®-based genome editing therapy for RAG1 deficiency

被引：0
|
作者：
Rhiel, M. [1 ,2 ]
Klermund, J. [1 ,2 ]
Jullierat, A. [3 ]
Andrieux, G. [4 ,5 ,6 ]
Rositzka, J. [1 ,2 ]
Duchateau, P. [7 ]
Cathomen, T. [1 ,2 ]
Cornu, T. I. [1 ,2 ]
机构：
[1] Univ Freiburg, Inst Transfus Med & Gene Therapy, Med Ctr, D-79106 Freiburg, Germany
[2] Univ Freiburg, Ctr Chron Immunodeficiency CCI, Med Ctr, D-79106 Freiburg, Germany
[3] Cellectis Inc, New York, NY 10016 USA
[4] Univ Freiburg, Inst Med Bioinformat & Syst Med, Med Ctr, D-79110 Freiburg, Germany
[5] German Canc Consortium DKTK, D-79106 Freiburg, Germany
[6] Partner Site Freiburg, German Canc Res Ctr DKFZ, D-79106 Freiburg, Germany
[7] Cellectis SA, F-75013 Paris, France
来源：
HUMAN GENE THERAPY | 2021年 / 32卷 / 19-20期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
OR34
引用
收藏
页码：A13 / A14
页数：2
相关论文
共 50 条
  • [1] Competitive Transplants in Rag1-/- Mice Support the Feasibility of Genome Editing for the Treatment of RAG1 Defect
    Castiello, Maria Carmina
    Capo, Valentina
    Sacchetti, Nicolo
    Penna, Sara
    Draghici, Elena
    Fontana, Elena
    Bortolomai, Ileana
    Bosticardo, Marita
    Notarangelo, Luigi D.
    Villa, Anna
    MOLECULAR THERAPY, 2017, 25 (05) : 92 - 92
  • [2] Preclinical lentiviral vector-mediated gene transfer for RAG1 and RAG2 deficiency
    Pike-Overzet, Karin
    Rodijk, Mark
    Ng, Yuk-Yin
    Baert, Miranda R. M.
    Schambach, Axel
    Baum, Christopher
    Wagemaker, Gerard
    van Dongen, Jacques J. M.
    Staal, Frank J. T.
    HUMAN GENE THERAPY, 2007, 18 (10) : 1011 - 1011
  • [3] Gene therapy strategies for RAG1 deficiency: Challenges and breakthroughs
    Gilioli, Giorgio
    Lankester, Arjan C.
    de Kivit, Sander
    Staal, Frank J. T.
    de Bruin, Lisa M. Ott
    IMMUNOLOGY LETTERS, 2024, 270
  • [4] Preclinical development of TALEN®-based genome editing in T cells for the treatment of Hyper-IgE-Syndrome
    Dettmer-Monaco, V.
    Haas, S. A.
    Jullierat, A.
    Andrieux, G.
    Rositzka, J.
    Grimbacher, B.
    Duchateau, P.
    Cornu, T. I.
    Cathomen, T.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A7 - A7
  • [5] Rag1 Deficiency Impairs Arteriogenesis in Mice
    Kumaraswami, Konda
    Arnholdt, Christoph
    Deindl, Elisabeth
    Lasch, Manuel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [6] UNUSUAL PRESENTATION OF HETEROZYGOUS RAG1 DEFICIENCY
    Burnett-Stinson, A.
    Fishbein, A.
    Gunderman, L.
    Saltoun, C.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S141 - S141
  • [7] Omenn syndrome: Partial Rag1 and Rag2 deficiency
    Bozzi, F
    Spanopoulou, E
    Santagata, S
    Strina, D
    Giliani, S
    Notarangelo, L
    Ochs, H
    Imberti, L
    Vezzoni, P
    Villa, A
    MOLECULAR IMMUNOLOGY, 1998, 35 (11-12) : 717 - 717
  • [8] RAG1 targeting in the genome is dominated by chromatin interactions mediated by the non-core regions of RAG1 and RAG2
    Maman, Yaakov
    Teng, Grace
    Seth, Rashu
    Kleinstein, Steven H.
    Schatz, David G.
    NUCLEIC ACIDS RESEARCH, 2016, 44 (20) : 9624 - 9637
  • [9] Targeted Genome Editing of Hematopoietic Stem Cells for Treating Recombination Activating Gene 1 (RAG1) Immunodeficiency
    Castiello, Maria Carmina
    Sacchetti, Nicolo
    Draghici, Elena
    Ferrari, Samuele
    Vavassori, Valentina
    Brandas, Chiara
    Minuta, Denise
    Di Verniere, Martina
    Jacob, Aurelien
    Calzoni, Enrica
    Bosticardo, Marita
    Notarangelo, Luigi Daniele
    Naldini, Luigi
    Villa, Anna
    MOLECULAR THERAPY, 2021, 29 (04) : 21 - 21
  • [10] Targeted Genome Editing of Haematopoietic Stem Cells for Treating Recombination Activating Gene 1 (RAG1) Immunodeficiency
    Castiello, M. C.
    Sacchetti, N.
    Brandas, C.
    Porcellini, S.
    Ferrari, S.
    Draghici, E.
    Vavassori, V.
    Minuta, D.
    Di Verniere, M.
    Jacob, A.
    Sergi, L. Sergi
    Bosticardo, M.
    Notarangelo, L. D.
    Genovese, P.
    Naldini, L.
    Villa, A.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A59 - A60
12345